Sen. John Kerry (D-Mass.) is hosting the discussions, which include companies from the Massachusetts Medical Device Industry Council.
Sen. Kerry said he hopes the talks, which include drugmakers, would build a collaborative, open relationship between the industry and its regulator.
Read the Boston Globe report on FDA oversight.
Related Articles on Devicemakers’ Concerns With FDA Oversight:
FDA Device Approval Process Stifles Innovation, Industry Survey Finds
FDA Pressed to Speed Up Device OKs Before Fee Reauthorization
Study: No Safety Benefit Recognized From Slower, Burdensome FDA Approval Process for Devices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.